Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Smooth Drug Development Selects CRO Starter Kit™ CTMS by Flex Databases

Published: Monday, September 23, 2013
Last Updated: Monday, September 23, 2013
Bookmark and Share
Flex Databases to release an electronic data capture (EDC) product in Q4 2013.

Flex Databases has announced that Smooth Drug Development has selected Flex CRO Starter Kit™ as its CTMS solution.

Smooth Drug Development is a full-service CRO headquartered in St. Petersburg, Russia. Smooth performs phase I-IV studies and runs 2 phase I units in St. Petersburg.

"We looked at a number of solutions on the market", said Dmitry Morozovsky, CEO of Smooth Drug Development. "In Flex Databases we found a solution which gives us the breadth of functionality we have not seen before, as Flex provide both PSA (such as timesheets, budgets, planning, utilization) and clinical research tools on the same platform. What especially caught our attention is the fact that Flex Databases are going to be releasing an electronic data capture (EDC) product in Q4 2013. We run a lot of bioequivalence studies, where operational efficiency is crucial, and having a single platform bringing together resource management, CTMS and EDC will allow us to shorten study timelines and further improve performance on the studies we run."

"Smooth Drug Development are a forward looking dynamic company who were quick to see the value of our platform", said Timur Galimov, Technical Director at Flex Databases.

Galimov continued, "We come across a lot of interest towards our upcoming EDC product, and we are pleased to have found an early adopter of our EDC technology even before the product has been released. Smooth Drug Development have one of the most comprehensive offerings we have seen in clinical research, and we are keen to help them grow by offering a platform which will streamline all the processes of their business".

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flex Databases Launches New Web Site
New website cements the company's unique positioning as a PSA company.
Tuesday, March 25, 2014
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos